STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
Status:
Completed
Trial end date:
2020-06-25
Target enrollment:
Participant gender:
Summary
To provide data demonstrating the safety and effectiveness of the Arctic Front Advance™
Cardiac CryoAblation Catheter for the treatment of recurrent symptomatic paroxysmal atrial
fibrillation, without the requirement that the subjects be drug refractory.
Phase:
N/A
Details
Lead Sponsor:
Medtronic Atrial Fibrillation Solutions Medtronic Cardiac Rhythm and Heart Failure